Ensysce Biosciences (ENSCW) Shares Outstanding (Diluted Average) (2020 - 2025)

Ensysce Biosciences (ENSCW) has 6 years of Shares Outstanding (Diluted Average) data on file, last reported at $2.6 million in Q4 2025.

• Shares Outstanding (Diluted Average) for Q4 2025 came in at $2.6 million, up 266.55% year-over-year; the trailing twelve-month figure through Dec 2025 was $2.6 million (up 266.55% YoY), and the FY2025 annual result was $2.6 million, up 266.55% from the prior year.
• Shares Outstanding (Diluted Average) slipped to $2.6 million in Q4 2025 per ENSCW's latest filing, from $2.9 million in the prior quarter.
• Over five years, Shares Outstanding (Diluted Average) peaked at $20.2 million in Q4 2021 and troughed at $127732.0 in Q2 2022.
• A 5-year average of $3.4 million and a median of $1.1 million in 2023 frame the typical range for Shares Outstanding (Diluted Average).
• The sharpest annual moves came in 2022 and 2023: Shares Outstanding (Diluted Average) tumbled 99.26% in 2022, then surged 2122.47% in 2023.
• A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $20.2 million in 2021, then slumped by 99.11% to $179925.0 in 2022, then declined by 16.11% to $150937.0 in 2023, then surged by 362.24% to $697686.0 in 2024, then jumped by 266.55% to $2.6 million in 2025.
• Business Quant data shows ENSCW's Shares Outstanding (Diluted Average) at $2.6 million in Q4 2025, $2.9 million in Q3 2025, and $2.2 million in Q2 2025.